Publication | Closed Access
Combination of chemotherapy and recombinant alpha-interferon in advanced non-small cell lung cancer: Multicentric randomized FONICAP trial report
23
Citations
27
References
1993
Year
This study indicates that the addition of recombinant alpha-IFN to CEP chemotherapy can increase response rate and toxicity to treatment without a positive effect on progression-free survival and survival.
| Year | Citations | |
|---|---|---|
Page 1
Page 1